Eisbach Bio GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.eisbach.bio
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid TumorHRR DeficiencyHomologous Recombination Deficiency
- Interventions
- First Posted Date
- 2024-07-29
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Eisbach Bio GmbH
- Target Recruit Count
- 144
- Registration Number
- NCT06525298
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
News
No news found